The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis
Cureus · 25.02.2024
DOI: 10.7759/cureus.54852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 25.02.2024. Verfasst von Yasser S Aladdin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU.
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
- Department of Neurology, King Abdulaziz Medical City, Jeddah, SAU.
Zitieren
APA
Aladdin, Y. S., Alqarni, D. A., Alamoudi, S. W., Alharbi, A. A., Fudhah, W. A., Alghamdi, G., & Attar, A. (2024). The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis. Cureus. https://doi.org/10.7759/cureus.54852
Vancouver
Aladdin YS, Alqarni DA, Alamoudi SW, Alharbi AA, Fudhah WA, Alghamdi G, et al. The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis. Cureus. 2024. doi:10.7759/cureus.54852
BibTeX
@article{Aladdin2024,
author = {Aladdin, Yasser S and Alqarni, Danah A and Alamoudi, Sheifa W and Alharbi, Abdulrahman A and Fudhah, Waad A and Alghamdi, Ghaida and Attar, Ahmed},
title = {The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis},
journal = {Cureus},
year = {2024},
doi = {10.7759/cureus.54852}
}
EUVIMED